Syngenta : Innovation based on SOLATENOL™ - ELATUS™ PLUS registered in France

On 28 July, Syngenta received registration in the rapporteur state, France, for the ELATUS™ Plus which is based on the novel carboxamide fungicide SOLATENOL™.
This is the first European registration for a SOLATENOL™ based product and will allow sales of ELATUS™ Plus in France this year, in time for the 2016-17 growing season.

Regulatory submissions for SOLATENOL™ products are under review throughout Europe with further regulatory approvals expected in due course.

In France SOLATENOL™ products will initially be sold under the ELATUS™ Plus brand in a range of co-packs focused on cereals.

SOLATENOL™ shows outstanding potency against all key cereal diseases and provides long lasting control. Together this results in very high levels of leaf protection and corresponding yield benefits for the grower.

About Syngenta

Syngenta is a leading agriculture company helping to improve global food security by enabling millions of farmers to make better use of available resources. Through world class science and innovative crop solutions, our 28,000 people in over 90 countries are working to transform how crops are grown. We are committed to rescuing land from degradation, enhancing biodiversity and revitalizing rural communities. To learn more visit www.syngenta.com and www.goodgrowthplan.com. Follow us on Twitter at www.twitter.com/Syngenta.

Cautionary statement regarding forward-looking statements

This document contains forward-looking statements, which can be identified by terminology such as 'expect', 'would', 'will', 'potential', 'plans', 'prospects', 'estimated', 'aiming', 'on track' and similar expressions. Such statements may be subject to risks and uncertainties that could cause the actual results to differ materially from these statements. We refer you to Syngenta's publicly available filings with the U.S. Securities and Exchange Commission for information about these and other risks and uncertainties. Syngenta assumes no obligation to update forward-looking statements to reflect actual results, changed assumptions or other factors. This document does not constitute, or form part of, any offer or invitation to sell or issue, or any solicitation of any offer, to purchase or subscribe for any ordinary shares in Syngenta AG, or Syngenta ADSs, nor shall it form the basis of, or be relied on in connection with, any contract therefor.